Ultragenyx Price To Sales Ratio from 2010 to 2024

RARE Stock  USD 47.12  0.12  0.25%   
Ultragenyx's Price To Sales Ratio is decreasing over the years with slightly volatile fluctuation. Price To Sales Ratio is expected to dwindle to 7.69. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Ultragenyx's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
8.09873478
Current Value
7.69
Quarterly Volatility
10.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ultragenyx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ultragenyx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 27.3 M, Interest Expense of 69.3 M or Selling General Administrative of 325.3 M, as well as many indicators such as Price To Sales Ratio of 7.69, Dividend Yield of 0.0028 or PTB Ratio of 16.58. Ultragenyx financial statements analysis is a perfect complement when working with Ultragenyx Valuation or Volatility modules.
  
Check out the analysis of Ultragenyx Correlation against competitors.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.

Latest Ultragenyx's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Ultragenyx over the last few years. Price to Sales Ratio is figured by comparing Ultragenyx stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Ultragenyx sales, a figure that is much harder to manipulate than other Ultragenyx multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Ultragenyx's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ultragenyx's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 8.35 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Ultragenyx Price To Sales Ratio Regression Statistics

Arithmetic Mean9,826
Geometric Mean589.77
Coefficient Of Variation109.42
Mean Deviation10,362
Median753.82
Standard Deviation10,751
Sample Variance115.6M
Range20.9K
R-Value(0.87)
Mean Square Error30.3M
R-Squared0.76
Significance0.000025
Slope(2,091)
Total Sum of Squares1.6B

Ultragenyx Price To Sales Ratio History

2024 7.69
2023 8.1
2022 8.92
2021 16.22
2020 31.08
2019 23.3
2018 42.03

About Ultragenyx Financial Statements

Ultragenyx stakeholders use historical fundamental indicators, such as Ultragenyx's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Ultragenyx investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ultragenyx's assets and liabilities are reflected in the revenues and expenses on Ultragenyx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ultragenyx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 8.10  7.69 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:
Check out the analysis of Ultragenyx Correlation against competitors.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.35)
Revenue Per Share
6.015
Quarterly Revenue Growth
0.423
Return On Assets
(0.24)
Return On Equity
(2.90)
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.